$PD-013Final survival results of a multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer patients refractory to standard therapies (C-TASK FORCE)$

PD-013Final survival results of a multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer patients refractory to standard therapies (C-TASK FORCE)

Yoshino, T.; Kuboki, Y.; Nishina, T.; Shinozaki, E.; Yamazaki, K.; Shitara, K.; Okamoto, W.; Kajiwara, T.; Matsumoto, T.; Tsushima, T.; Mochizuki, N.; Fukutani, M.; Nakamoto, M.; Hasegawa, H.; Sugama, A.; Nomura, S.; Sato, A.; Ohtsu, A.

期刊名称Annals of Oncology
作者Yoshino, T.; Kuboki, Y.; Nishina, T.; Shinozaki, E.; Yamazaki, K.; Shitara, K.; Okamoto, W.; Kajiwara, T.; Matsumoto, T.; Tsushima, T.; Mochizuki, N.; Fukutani, M.; Nakamoto, M.; Hasegawa, H.; Sugama, A.; Nomura, S.; Sato, A.; Ohtsu, A.
卷第27卷
印刷ISSN0923-7534
电子ISSN1569-8041
文件大小171.18KB
发表时间2016-06
DOI10.1093/annonc/mdw200.13

发现好书期刊，享受阅读乐趣

PD-013Final survival results of a multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer patients refractory to standard therapies (C-TASK FORCE)